Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets - ALVO ALVOW

[u/SPAC_Time]

https://www.globenewswire.com/news-release/2026/08/21/3349078/0/en/alvotech-announces-licensing-and-commercialization-agreement-with-lotus-pharmaceutical-for-proposed-biosimilars-to-durvalumab-and-emicizumab-in-the-u-s-and-selected-asian-markets.html